(Q54363293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Charles Dumontet

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Lars Jordheim

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

A Doléans-Jordheim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

E Bergeron

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

F Bereyziat

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

S Ben-Larbi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

M-A Mazoyer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

F Morfin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

J Freney

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

15 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1249-1256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10096-011-1220-3

28 January 2020

exact match

0 references

cites work

Antimicrobial resistance in Europe and its potential impact on empirical therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Microbiology. Desperately seeking new antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

21 January 2018

The bacteria fight back

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

New antimicrobial agents for the treatment of bacterial infections in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

New treatments for methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Functional, biophysical, and structural bases for antibacterial activity of tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Antibacterial activity of fluoroquinolones in combination with zidovudine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Mechanisms of zidovudine resistance in bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Bias between the left and right inverted repeats during IS911 targeted insertion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1220-3

Isolation of zidovudine resistant Escherichia coli from AIDS patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21494911

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Canadian multicenter azidothymidine trial: AZT pharmacokinetics

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21494911

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral beta-lactam antibiotics is associated with alterations of PBP2x

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21494911

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10096-011-1220-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21494911%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference